Sequence analysis of V4-34-encoded antibodies from single B cells of two patients with systemic lupus erythematosus (SLE)

被引:0
|
作者
Mockridge, CI
Chapman, CJ
Spellerberg, MB
Sheth, B
Fleming, TP
Isenberg, DA
Stevenson, FK [1 ]
机构
[1] Southampton Univ Hosp Trust, Mol Immunol Grp, Tenovus Lab, Southampton SO16 6YD, Hants, England
[2] Univ Southampton, Div Cell Sci, Sch Biol Sci, Southampton, Hants, England
[3] Middlesex Univ Hosp, Univ London London Hosp, Ctr Rheumatol, London N17 8HR, England
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1998年 / 114卷 / 01期
关键词
anti-DNA; V-genes; systemic lupus erythematosus; B cells; single cell;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SLE is an autoimmune disease characterized by the presence of autoantibodies against double-stranded (ds)DNA. A large proportion (approx. 40%) of patients with lupus also have increased levels of serum immunoglobulin encoded by the V4-34 heavy chain gene, which often fluctuate with disease activity, and this gene is utilized by a subset of anti-dsDNA antibodies. In order to probe the nature of the V4-34- encoded immunoglobulin, B cells were isolated from the blood of two patients with active disease, using the 9G4 MoAb specific for the immunoglobulin gene product. Following cell picking, single-cell polymerase chain reaction (PCR) amplification of cDNA was used to investigate bath VH and VL genes. Sequences were obtained from B cells synthesizing IgM (n = 10), IgG (n = 4) and IgA (n = 1). For VH, all were derived from V4-34 as expected, and the isotype-switched sequences and 2/6 IgM sequences were somatically mutated. In contrast, VL (12 kappa and 3 lambda) showed a low level of mutation, possibly indicating secondary rearrangements. The three most highly mutated VH sequences were associated with unmutated VL sequences. Analysis of the distribution of mutations revealed only minor clustering in complementarity-determining regions (CDRs) characteristic of antigen selection. The CDR3 lengths of VH ranged from five to 19 amino acids, and in 3/15 there was evidence of an excess of positively charged amino acids, compared with the normal expressed repertoire. Basic amino acids were also found at the V-L-J(L) junctions in 4/15. These findings provide insight into the V4-34-V-L gene combinations used by B cells in patients with SLE which might have clinical relevance.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 50 条
  • [41] Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus
    Cruz-Gonzalez, D. de J.
    Gomez-Martin, D.
    Layseca-Espinosa, E.
    Baranda, L.
    Abud-Mendoza, C.
    Alcocer-Varela, J.
    Gonzalez-Amaro, R.
    Monsivais-Urenda, A. E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (03): : 288 - 300
  • [42] INCREASED EXPRESSION OF BCL2 PROTEIN IN PERIPHERAL B-CELLS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    KUMAGAI, S
    YANAGIDA, H
    TSUJIMOTO, Y
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S76 - S76
  • [43] Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus
    Gies, Vincent
    Schickel, Jean-Nicolas
    Jung, Sophie
    Joublin, Aurelie
    Glauzy, Salome
    Knapp, Anne-Marie
    Soley, Anne
    Poindron, Vincent
    Guffroy, Aurelien
    Choi, Jin-Young
    Gottenberg, Jacques-Eric
    Anolik, Jennifer H.
    Martin, Thierry
    Soulas-Sprauel, Pauline
    Meffre, Eric
    Korganow, Anne-Sophie
    JCI INSIGHT, 2018, 3 (05):
  • [44] SHOULD ANTIBODIES TO DOMAIN I B2-GLYCOPROTEIN 1 BE INVESTIGATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)?
    Cheldieva, F.
    Reshetnyak, T.
    Cherkasova, M.
    Glukhova, S.
    Lila, A.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1374 - 1375
  • [45] Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE)
    Linan-Rico, L.
    Hernandez-Castro, B.
    Doniz-Padilla, L.
    Portillo-Salazar, H.
    Baranda, L.
    Cruz-Munoz, M. E.
    Gonzalez-Amaro, R.
    LUPUS, 2015, 24 (11) : 1184 - 1190
  • [46] EXPANSION OF CD4+CXCR3+T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CORRELATES WITH SUBCLINICAL ATHEROSCLEROSIS
    Sacre, K.
    Escoubet, B.
    Charles, N.
    Chauveheid, M. -P.
    Papo, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 280 - 280
  • [47] Molecular and genetic characterization of two anti-DNA antibodies derived from patients with systemic lupus erythematosus
    Y. W. Song
    Hyun Ah Kim
    Eun Bong Lee
    Jung Kon Kim
    J. H. Chung
    Eun Suk Chung
    Kyeong Man Hong
    H. J. Back
    Rheumatology International, 1998, 17 : 223 - 228
  • [48] Molecular and genetic characterization of two anti-DNA antibodies derived from patients with systemic lupus erythematosus
    Song, YW
    Kim, HA
    Lee, EB
    Baek, HJ
    Kim, JK
    Chung, JH
    Chung, ES
    Hong, KM
    RHEUMATOLOGY INTERNATIONAL, 1998, 17 (06) : 223 - 228
  • [49] Perforin level in CD4+ T cells from patients with systemic lupus erythematosus
    Kozlowska, Anna
    Hrycaj, Pawel
    Lacki, Jan K.
    Jagodzinski, Pawel Piotr
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1627 - 1633
  • [50] Perforin level in CD4+ T cells from patients with systemic lupus erythematosus
    Anna Kozłowska
    Paweł Hrycaj
    Jan K. Łącki
    Paweł Piotr Jagodziński
    Rheumatology International, 2010, 30 : 1627 - 1633